nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Dysgeusia—Triamcinolone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Tobramycin—Nausea—Cladribine—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Tobramycin—Vertigo—Prednisolone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Tobramycin—Eye disorder—Dexamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Tobramycin—Eye disorder—Betamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Tobramycin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Tobramycin—Back pain—Triamcinolone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Tobramycin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Tobramycin—Asthma—Methotrexate—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Tobramycin—Angiopathy—Betamethasone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Tobramycin—Angiopathy—Dexamethasone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Tobramycin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Tobramycin—Eosinophilia—Methotrexate—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Tobramycin—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Tobramycin—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Tobramycin—Pain—Mitoxantrone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Tobramycin—Diarrhoea—Azathioprine—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Tobramycin—Discomfort—Prednisolone—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Tobramycin—Angioedema—Triamcinolone—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Tobramycin—Angioedema—Methylprednisolone—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Tobramycin—Erythema—Dexamethasone—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Tobramycin—Erythema—Betamethasone—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Tobramycin—Malaise—Triamcinolone—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Tobramycin—Malaise—Methylprednisolone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Tobramycin—Vertigo—Triamcinolone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Tobramycin—Vertigo—Methylprednisolone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Tobramycin—Connective tissue disorder—Prednisone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Tobramycin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Tobramycin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Tobramycin—Dizziness—Azathioprine—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Tobramycin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Tobramycin—Cough—Triamcinolone—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Tobramycin—Urticaria—Mitoxantrone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Tobramycin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Tobramycin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Tobramycin—Myalgia—Triamcinolone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Tobramycin—Vomiting—Azathioprine—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Tobramycin—Myalgia—Methylprednisolone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Tobramycin—Eye disorder—Prednisone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Tobramycin—Infestation NOS—Methotrexate—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Infestation—Methotrexate—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Rash—Azathioprine—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Dermatitis—Azathioprine—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Discomfort—Triamcinolone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Tobramycin—Discomfort—Methylprednisolone—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Tobramycin—Headache—Azathioprine—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Tobramycin—Renal failure—Methotrexate—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Tobramycin—Angioedema—Dexamethasone—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Tobramycin—Angioedema—Betamethasone—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Tobramycin—Stomatitis—Methotrexate—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Tobramycin—Angiopathy—Prednisone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Tobramycin—Confusional state—Methylprednisolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Tobramycin—Immune system disorder—Prednisone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Tobramycin—Malaise—Betamethasone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Tobramycin—Malaise—Dexamethasone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Tobramycin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Tobramycin—Vertigo—Dexamethasone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Tobramycin—Vertigo—Betamethasone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Tobramycin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Tobramycin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Tobramycin—Epistaxis—Methotrexate—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Tobramycin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Tobramycin—Paraesthesia—Prednisolone—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Tobramycin—Nausea—Azathioprine—multiple sclerosis	0.00104	0.00104	CcSEcCtD
Tobramycin—Skin disorder—Methylprednisolone—multiple sclerosis	0.00103	0.00103	CcSEcCtD
Tobramycin—Erythema—Prednisone—multiple sclerosis	0.00103	0.00103	CcSEcCtD
Tobramycin—Agranulocytosis—Methotrexate—multiple sclerosis	0.00103	0.00103	CcSEcCtD
Tobramycin—Asthenia—Mitoxantrone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Tobramycin—Myalgia—Betamethasone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Tobramycin—Myalgia—Dexamethasone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Tobramycin—Discomfort—Betamethasone—multiple sclerosis	0.000995	0.000995	CcSEcCtD
Tobramycin—Discomfort—Dexamethasone—multiple sclerosis	0.000995	0.000995	CcSEcCtD
Tobramycin—Pain—Prednisolone—multiple sclerosis	0.00099	0.00099	CcSEcCtD
Tobramycin—Pharyngitis—Methotrexate—multiple sclerosis	0.000982	0.000982	CcSEcCtD
Tobramycin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000977	0.000977	CcSEcCtD
Tobramycin—Vision blurred—Prednisone—multiple sclerosis	0.000971	0.000971	CcSEcCtD
Tobramycin—Urethral disorder—Methotrexate—multiple sclerosis	0.00097	0.00097	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00097	0.00097	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000968	0.000968	CcSEcCtD
Tobramycin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000966	0.000966	CcSEcCtD
Tobramycin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000966	0.000966	CcSEcCtD
Tobramycin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000965	0.000965	CcSEcCtD
Tobramycin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000956	0.000956	CcSEcCtD
Tobramycin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000956	0.000956	CcSEcCtD
Tobramycin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000954	0.000954	CcSEcCtD
Tobramycin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000954	0.000954	CcSEcCtD
Tobramycin—Visual impairment—Methotrexate—multiple sclerosis	0.000953	0.000953	CcSEcCtD
Tobramycin—Anaemia—Prednisone—multiple sclerosis	0.000952	0.000952	CcSEcCtD
Tobramycin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000949	0.000949	CcSEcCtD
Tobramycin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000947	0.000947	CcSEcCtD
Tobramycin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000947	0.000947	CcSEcCtD
Tobramycin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000946	0.000946	CcSEcCtD
Tobramycin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000946	0.000946	CcSEcCtD
Tobramycin—Angioedema—Prednisone—multiple sclerosis	0.000942	0.000942	CcSEcCtD
Tobramycin—Malaise—Prednisone—multiple sclerosis	0.000929	0.000929	CcSEcCtD
Tobramycin—Vertigo—Prednisone—multiple sclerosis	0.000926	0.000926	CcSEcCtD
Tobramycin—Eye disorder—Methotrexate—multiple sclerosis	0.000925	0.000925	CcSEcCtD
Tobramycin—Tinnitus—Methotrexate—multiple sclerosis	0.000922	0.000922	CcSEcCtD
Tobramycin—Anorexia—Dexamethasone—multiple sclerosis	0.000921	0.000921	CcSEcCtD
Tobramycin—Anorexia—Betamethasone—multiple sclerosis	0.000921	0.000921	CcSEcCtD
Tobramycin—Urticaria—Prednisolone—multiple sclerosis	0.000919	0.000919	CcSEcCtD
Tobramycin—Pain—Triamcinolone—multiple sclerosis	0.00091	0.00091	CcSEcCtD
Tobramycin—Angiopathy—Methotrexate—multiple sclerosis	0.000898	0.000898	CcSEcCtD
Tobramycin—Vomiting—Mitoxantrone—multiple sclerosis	0.000897	0.000897	CcSEcCtD
Tobramycin—Immune system disorder—Methotrexate—multiple sclerosis	0.000894	0.000894	CcSEcCtD
Tobramycin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000892	0.000892	CcSEcCtD
Tobramycin—Rash—Mitoxantrone—multiple sclerosis	0.00089	0.00089	CcSEcCtD
Tobramycin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000889	0.000889	CcSEcCtD
Tobramycin—Headache—Mitoxantrone—multiple sclerosis	0.000884	0.000884	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00088	0.00088	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00088	0.00088	CcSEcCtD
Tobramycin—Myalgia—Prednisone—multiple sclerosis	0.000877	0.000877	CcSEcCtD
Tobramycin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000877	0.000877	CcSEcCtD
Tobramycin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000875	0.000875	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000871	0.000871	CcSEcCtD
Tobramycin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000868	0.000868	CcSEcCtD
Tobramycin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000867	0.000867	CcSEcCtD
Tobramycin—Paraesthesia—Betamethasone—multiple sclerosis	0.000867	0.000867	CcSEcCtD
Tobramycin—Discomfort—Prednisone—multiple sclerosis	0.000867	0.000867	CcSEcCtD
Tobramycin—Erythema—Methotrexate—multiple sclerosis	0.000861	0.000861	CcSEcCtD
Tobramycin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000853	0.000853	CcSEcCtD
Tobramycin—Urticaria—Triamcinolone—multiple sclerosis	0.000846	0.000846	CcSEcCtD
Tobramycin—Urticaria—Methylprednisolone—multiple sclerosis	0.000844	0.000844	CcSEcCtD
Tobramycin—Dysgeusia—Methotrexate—multiple sclerosis	0.000843	0.000843	CcSEcCtD
Tobramycin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000841	0.000841	CcSEcCtD
Tobramycin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000841	0.000841	CcSEcCtD
Tobramycin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00084	0.00084	CcSEcCtD
Tobramycin—Decreased appetite—Dexamethasone—multiple sclerosis	0.00084	0.00084	CcSEcCtD
Tobramycin—Decreased appetite—Betamethasone—multiple sclerosis	0.00084	0.00084	CcSEcCtD
Tobramycin—Nausea—Mitoxantrone—multiple sclerosis	0.000838	0.000838	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000834	0.000834	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000834	0.000834	CcSEcCtD
Tobramycin—Back pain—Methotrexate—multiple sclerosis	0.000833	0.000833	CcSEcCtD
Tobramycin—Pain—Betamethasone—multiple sclerosis	0.000826	0.000826	CcSEcCtD
Tobramycin—Pain—Dexamethasone—multiple sclerosis	0.000826	0.000826	CcSEcCtD
Tobramycin—Nervous system disorder—Prednisone—multiple sclerosis	0.000825	0.000825	CcSEcCtD
Tobramycin—Skin disorder—Prednisone—multiple sclerosis	0.000817	0.000817	CcSEcCtD
Tobramycin—Vision blurred—Methotrexate—multiple sclerosis	0.000812	0.000812	CcSEcCtD
Tobramycin—Anorexia—Prednisone—multiple sclerosis	0.000802	0.000802	CcSEcCtD
Tobramycin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000799	0.000799	CcSEcCtD
Tobramycin—Anaemia—Methotrexate—multiple sclerosis	0.000796	0.000796	CcSEcCtD
Tobramycin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000796	0.000796	CcSEcCtD
Tobramycin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000796	0.000796	CcSEcCtD
Tobramycin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00079	0.00079	CcSEcCtD
Tobramycin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00079	0.00079	CcSEcCtD
Tobramycin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000784	0.000784	CcSEcCtD
Tobramycin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000782	0.000782	CcSEcCtD
Tobramycin—Malaise—Methotrexate—multiple sclerosis	0.000777	0.000777	CcSEcCtD
Tobramycin—Vertigo—Methotrexate—multiple sclerosis	0.000774	0.000774	CcSEcCtD
Tobramycin—Leukopenia—Methotrexate—multiple sclerosis	0.000771	0.000771	CcSEcCtD
Tobramycin—Urticaria—Dexamethasone—multiple sclerosis	0.000767	0.000767	CcSEcCtD
Tobramycin—Urticaria—Betamethasone—multiple sclerosis	0.000767	0.000767	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000766	0.000766	CcSEcCtD
Tobramycin—Dizziness—Prednisolone—multiple sclerosis	0.000765	0.000765	CcSEcCtD
Tobramycin—Asthenia—Triamcinolone—multiple sclerosis	0.000764	0.000764	CcSEcCtD
Tobramycin—Abdominal pain—Betamethasone—multiple sclerosis	0.000763	0.000763	CcSEcCtD
Tobramycin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000763	0.000763	CcSEcCtD
Tobramycin—Body temperature increased—Betamethasone—multiple sclerosis	0.000763	0.000763	CcSEcCtD
Tobramycin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000763	0.000763	CcSEcCtD
Tobramycin—Asthenia—Methylprednisolone—multiple sclerosis	0.000762	0.000762	CcSEcCtD
Tobramycin—Paraesthesia—Prednisone—multiple sclerosis	0.000755	0.000755	CcSEcCtD
Tobramycin—Pruritus—Triamcinolone—multiple sclerosis	0.000753	0.000753	CcSEcCtD
Tobramycin—Cough—Methotrexate—multiple sclerosis	0.000752	0.000752	CcSEcCtD
Tobramycin—Pruritus—Methylprednisolone—multiple sclerosis	0.000751	0.000751	CcSEcCtD
Tobramycin—Chest pain—Methotrexate—multiple sclerosis	0.000733	0.000733	CcSEcCtD
Tobramycin—Myalgia—Methotrexate—multiple sclerosis	0.000733	0.000733	CcSEcCtD
Tobramycin—Decreased appetite—Prednisone—multiple sclerosis	0.000731	0.000731	CcSEcCtD
Tobramycin—Rash—Prednisolone—multiple sclerosis	0.00073	0.00073	CcSEcCtD
Tobramycin—Dermatitis—Prednisolone—multiple sclerosis	0.000729	0.000729	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000728	0.000728	CcSEcCtD
Tobramycin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000727	0.000727	CcSEcCtD
Tobramycin—Headache—Prednisolone—multiple sclerosis	0.000725	0.000725	CcSEcCtD
Tobramycin—Discomfort—Methotrexate—multiple sclerosis	0.000724	0.000724	CcSEcCtD
Tobramycin—Confusional state—Methotrexate—multiple sclerosis	0.000709	0.000709	CcSEcCtD
Tobramycin—Dizziness—Triamcinolone—multiple sclerosis	0.000704	0.000704	CcSEcCtD
Tobramycin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000703	0.000703	CcSEcCtD
Tobramycin—Dizziness—Methylprednisolone—multiple sclerosis	0.000702	0.000702	CcSEcCtD
Tobramycin—Feeling abnormal—Prednisone—multiple sclerosis	0.000693	0.000693	CcSEcCtD
Tobramycin—Asthenia—Dexamethasone—multiple sclerosis	0.000693	0.000693	CcSEcCtD
Tobramycin—Asthenia—Betamethasone—multiple sclerosis	0.000693	0.000693	CcSEcCtD
Tobramycin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000689	0.000689	CcSEcCtD
Tobramycin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000688	0.000688	CcSEcCtD
Tobramycin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000688	0.000688	CcSEcCtD
Tobramycin—Nausea—Prednisolone—multiple sclerosis	0.000687	0.000687	CcSEcCtD
Tobramycin—Pruritus—Dexamethasone—multiple sclerosis	0.000683	0.000683	CcSEcCtD
Tobramycin—Pruritus—Betamethasone—multiple sclerosis	0.000683	0.000683	CcSEcCtD
Tobramycin—Skin disorder—Methotrexate—multiple sclerosis	0.000683	0.000683	CcSEcCtD
Tobramycin—Vomiting—Triamcinolone—multiple sclerosis	0.000677	0.000677	CcSEcCtD
Tobramycin—Vomiting—Methylprednisolone—multiple sclerosis	0.000675	0.000675	CcSEcCtD
Tobramycin—Rash—Triamcinolone—multiple sclerosis	0.000671	0.000671	CcSEcCtD
Tobramycin—Dermatitis—Triamcinolone—multiple sclerosis	0.00067	0.00067	CcSEcCtD
Tobramycin—Anorexia—Methotrexate—multiple sclerosis	0.00067	0.00067	CcSEcCtD
Tobramycin—Rash—Methylprednisolone—multiple sclerosis	0.00067	0.00067	CcSEcCtD
Tobramycin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000669	0.000669	CcSEcCtD
Tobramycin—Urticaria—Prednisone—multiple sclerosis	0.000668	0.000668	CcSEcCtD
Tobramycin—Headache—Triamcinolone—multiple sclerosis	0.000667	0.000667	CcSEcCtD
Tobramycin—Headache—Methylprednisolone—multiple sclerosis	0.000665	0.000665	CcSEcCtD
Tobramycin—Body temperature increased—Prednisone—multiple sclerosis	0.000665	0.000665	CcSEcCtD
Tobramycin—Abdominal pain—Prednisone—multiple sclerosis	0.000665	0.000665	CcSEcCtD
Tobramycin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000661	0.000661	CcSEcCtD
Tobramycin—Diarrhoea—Betamethasone—multiple sclerosis	0.000661	0.000661	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00064	0.00064	CcSEcCtD
Tobramycin—Dizziness—Dexamethasone—multiple sclerosis	0.000639	0.000639	CcSEcCtD
Tobramycin—Dizziness—Betamethasone—multiple sclerosis	0.000639	0.000639	CcSEcCtD
Tobramycin—Nausea—Triamcinolone—multiple sclerosis	0.000632	0.000632	CcSEcCtD
Tobramycin—Paraesthesia—Methotrexate—multiple sclerosis	0.000631	0.000631	CcSEcCtD
Tobramycin—Nausea—Methylprednisolone—multiple sclerosis	0.000631	0.000631	CcSEcCtD
Tobramycin—Dyspnoea—Methotrexate—multiple sclerosis	0.000627	0.000627	CcSEcCtD
Tobramycin—Hypersensitivity—Prednisone—multiple sclerosis	0.00062	0.00062	CcSEcCtD
Tobramycin—Vomiting—Betamethasone—multiple sclerosis	0.000614	0.000614	CcSEcCtD
Tobramycin—Vomiting—Dexamethasone—multiple sclerosis	0.000614	0.000614	CcSEcCtD
Tobramycin—Decreased appetite—Methotrexate—multiple sclerosis	0.000611	0.000611	CcSEcCtD
Tobramycin—Rash—Betamethasone—multiple sclerosis	0.000609	0.000609	CcSEcCtD
Tobramycin—Rash—Dexamethasone—multiple sclerosis	0.000609	0.000609	CcSEcCtD
Tobramycin—Dermatitis—Dexamethasone—multiple sclerosis	0.000608	0.000608	CcSEcCtD
Tobramycin—Dermatitis—Betamethasone—multiple sclerosis	0.000608	0.000608	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000607	0.000607	CcSEcCtD
Tobramycin—Headache—Dexamethasone—multiple sclerosis	0.000605	0.000605	CcSEcCtD
Tobramycin—Headache—Betamethasone—multiple sclerosis	0.000605	0.000605	CcSEcCtD
Tobramycin—Asthenia—Prednisone—multiple sclerosis	0.000603	0.000603	CcSEcCtD
Tobramycin—Pain—Methotrexate—multiple sclerosis	0.000601	0.000601	CcSEcCtD
Tobramycin—Pruritus—Prednisone—multiple sclerosis	0.000595	0.000595	CcSEcCtD
Tobramycin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000579	0.000579	CcSEcCtD
Tobramycin—Diarrhoea—Prednisone—multiple sclerosis	0.000575	0.000575	CcSEcCtD
Tobramycin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000575	0.000575	CcSEcCtD
Tobramycin—Nausea—Betamethasone—multiple sclerosis	0.000574	0.000574	CcSEcCtD
Tobramycin—Nausea—Dexamethasone—multiple sclerosis	0.000574	0.000574	CcSEcCtD
Tobramycin—Urticaria—Methotrexate—multiple sclerosis	0.000558	0.000558	CcSEcCtD
Tobramycin—Dizziness—Prednisone—multiple sclerosis	0.000556	0.000556	CcSEcCtD
Tobramycin—Abdominal pain—Methotrexate—multiple sclerosis	0.000556	0.000556	CcSEcCtD
Tobramycin—Body temperature increased—Methotrexate—multiple sclerosis	0.000556	0.000556	CcSEcCtD
Tobramycin—Vomiting—Prednisone—multiple sclerosis	0.000535	0.000535	CcSEcCtD
Tobramycin—Rash—Prednisone—multiple sclerosis	0.00053	0.00053	CcSEcCtD
Tobramycin—Dermatitis—Prednisone—multiple sclerosis	0.00053	0.00053	CcSEcCtD
Tobramycin—Headache—Prednisone—multiple sclerosis	0.000527	0.000527	CcSEcCtD
Tobramycin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000518	0.000518	CcSEcCtD
Tobramycin—Asthenia—Methotrexate—multiple sclerosis	0.000504	0.000504	CcSEcCtD
Tobramycin—Nausea—Prednisone—multiple sclerosis	0.0005	0.0005	CcSEcCtD
Tobramycin—Pruritus—Methotrexate—multiple sclerosis	0.000497	0.000497	CcSEcCtD
Tobramycin—Diarrhoea—Methotrexate—multiple sclerosis	0.000481	0.000481	CcSEcCtD
Tobramycin—Dizziness—Methotrexate—multiple sclerosis	0.000465	0.000465	CcSEcCtD
Tobramycin—Vomiting—Methotrexate—multiple sclerosis	0.000447	0.000447	CcSEcCtD
Tobramycin—Rash—Methotrexate—multiple sclerosis	0.000443	0.000443	CcSEcCtD
Tobramycin—Dermatitis—Methotrexate—multiple sclerosis	0.000443	0.000443	CcSEcCtD
Tobramycin—Headache—Methotrexate—multiple sclerosis	0.00044	0.00044	CcSEcCtD
Tobramycin—Nausea—Methotrexate—multiple sclerosis	0.000418	0.000418	CcSEcCtD
